also, sexy summer hair. oshgsz i'm jim cramer. welcome to my world. >> you need to get in the game. >> firms are going to go out of business, and he's nuts. they're nuts. they know nothing. >> i always like to say there's a bull market somewhere. >> "mad money," you can't afford to miss it. hey, i'm cramer. welcome to "mad money." welcome to cramerica. other people want to make friends. i'm just trying to save you a little money. my job isn't just to entertain with but to educate you. call me at 1-800-743-cnbc. many stocks aren't going to make the quarter. [ baby crying ] >> that's what this roller coaster of a market really told us underneath today where the dow closed down 25 points. s&p gave up .21% and the nasdaq .9%. mostly rumors of a european compromise to save loser

countries. can't invest in rumors. european leaders did apparently agree to spend $150 million to stimulate growth, a tenth of what's needed. nice thought. let's talk about facts. for much of the year stocks trade off of big trends. you have a strong durable goods number and the big institutions can set the price of stocks. they come in and buy etfs filled with industrials. we hear about a new product, say from apple. the same buyers buy up all the makers the innards of the products. we buy the oil. decline in commodities means we purchase packaged goods companies. in short we take what's known as the macro and we daily shoehorn the micro meaning we pick stocks to fit the big picture thesis and we buy. as someone who used to trade for a living i made a pretty penny

doing shoehorn trades anticipating broad sector moves. but all good things must come to an end. four times a year this extrapolation game making judgments that encompass individual stocks as a part of some broader themes run into something unassailable. the cold hard facts about how these companies are really doing. we call it earnings season but for me it's the end of the news vacuum that allows us to buy or sell stocks on perception and forces us to take into the cold hard facts of reality. today we are being gripped with the end of that vacuum because it's the end of the quarter, people. i'm sure some of you thought the markets sold off this morning because the supreme court ratified the president's health care plan. some retailers have to offer more coverage to hundreds of thousands of employees thanks to obamacare and those stocks sold off but they weren't hit hard.

lots of unaffected stocks were hit much harder. just one of those big bad events. they generate uncertainty until they are resolved and the event is in the past. the resolution of the health care situation allows companies to plan, budgets to be made and gets us unstuck from paralysis caused by the unknown. once you get past the big bad event you are in better shape, even if the decision may not have been all that positive for business. that's how the market can shrug off the news without a setback considering we barely began to give up yesterday's gains. some of the decline can be attributed to usual european dithering but it seems to have put the world on edge more because the germans say there is no compromise. we rallied almost a percent yesterday with the same set of circumstances on hand. what's really happening now is we are at last on the eve of the next earnings season where we'll make decisions based on how companies are really doing not faux reactions to macro inputs.

here's your playbook on what to expect. first of all we have the financials. the largest component of the s&p 500. today you saw the ugly face of the international banks. rumored story about how much jpmorgan lost in europe is not clear, frankly. that's not as important as the dearth of business the banks are faced with. we can trade the banks all we want off fed comments or bank scandals. what really matters is activity. and there's been almost none. that leads to huge number cuts for the banks which will further batter the group. that's the international banks. the domestic banks are more levered to how many homes they own in the inventory and how many new loans they made to get out of the inventory. they won't make as much money as we'd like given how many of the stocks have run the quarter and they will head lower. i expect as housing continues its recovery they will be fine. not great. but if the domestic banks get hammered along with the ones that sing the internationale they will be better buys than

sells. tech, get ready for severe disappointments. i can't think of a single technology company having a terrific quarter. not even apple because of the gap between iphone 4 and 5. hold apple through the valley. we heard from jabil and i didn't get a sense that we'd get good numbers from any company until the fall including research in motion which reported a definition of hideous quarter after the bell. big steaming loss. unless you can handle the pain, do not own tech. do not. do not. do not. it has not fallen low enough yet to eliminate the risk. europe is the second or third largest market for almost all of these tech plays. that's just a killer. that's awful. no good pin action in the group. i think the oil is downright disastrous. you have to put yourself in management's shoes.

oil was at a hundred dollars a barrel. they are going into a quarter where it's $77, $78. i bet every company will have nothing good to say. earnings estimates will be slashed across the board. don't think they have bottomed. i wouldn't own them unless you have yield support meaning they yield at least 3.5% and maybe 4% when we're done. how about health care? here is an instance where the certainty from obamacare will be helpful. stocks trade on guidance. these companies were all about suspending guidance while waiting for the key supreme court ruling. the supremes have ruled and it's bullish for everyone in the space. i would buy the health care stocks here. they are right. they have come down. retail. the group's grown worrisome. as anyone can see from bed, bath & beyond, family dollar which did recover. the latest to blow out, nike after the bell didn't hold the hundred level. the retailers won't deliver

great numbers because the weather played havoc with the business. they are in the exact opposite situation from the oil companies. these retailers and restaurants went into the quarter with gas at $4. supposed to go to $5. now $3.80 going to $3.50. these will be terrific stories now that it looks like they have all been beaten upside the head before they report. i like that. they have been softened. same with packaged good stocks. we heard from ken powell, the ceo of general mills coming out of the worst commodity spike in 30 years. ask conagra. finally the industrials. oh, boy. i don't know many industrial companies that aren't huge in europe. they moved there because the u.s. didn't have growth. they spent years building up the european businesses. when they speak they are speaking about the future of europe.

we don't know the future of europe, but it's darker than the past. one thing is for certain. doesn't like there are as many fords in the future. horrendous european guidance. i wanted to close my eyes, but i had to read it. the big bad health care event is behind us now. finally get some certainty. always positive. now the focus will be on earnings because it's the end of the vacuum. now you know the winners from the losers. pick accordingly. don't be afraid to trim in the groups that i expect to disappoint. no matter where they are, they can and will go lower if they do let us down, as research in motion demonstrated again, even though it was already down more than 70% over the last sorry year of that stock's existence. heather in oregon, please. heather. >> caller: hey, jim. boo-yah from portland, oregon! >> boo-yah. how's portland doing? >> caller: what was that? >> how is portland doing? >> caller: portland is doing fabulous. we always want more sunshine, but hopefully it's coming soon. >> i hope so, too. how can i help you? >> caller: hey, i know that

paychex earnings report came out yesterday and it wasn't as bright as people were expecting. what i'm curious about as an employee and just to hear your thoughts on adp, automatic data processing. >> i think employment growth is very weak in this country. i think therefore you are not going to get anything better from auto data that you got from paychex. stay on the sidelines. nothing to write home about. eduardo in texas. eduardo. >> caller: yes, jim. good afternoon. this is eduardo in texas. my question is prudential, pru. after the quarter today do you think it's a sell, sell, sell? >> i think prudential had a bad last quarter. i'm mystified by it. my charitable trust blew out of it before the quarter. once it came down you look again. no, $46 doesn't tempt me one

single bit. steve in pennsylvania, please. steve. >> caller: boo-yah, jim. >> boo-yah, steve. what's up? >> caller: i'd like to say that i like watching you in the morning. >> thank you. >> caller: i watch you every night. >> you're terrific. thank you very much. thank you. >> caller: okay. i'm having a hard time with one of yours and my favorite stock. cmg, chipotle. i know with consumer sentiment and discretionary spending numbers coming in really low i'm just -- i just don't understand how we lost $25 yesterday and $25 today. >> it's a good point. the stock is still up more than 11%. here's one of the problems. we are in a real news vacuum. i'm talking about it tonight. the news vacuum isn't good. no one is saying anything positive. i think we have to wait and see. i think that core franchise is a good one. the big bad health care ruling is now at last behind us. ♪ hallelujah now we have the opportunity to

separate the bad from the good. choose wisely. i'm here to help you every step of the way. "mad money" will be right back. >> announcer: coming up -- down but not out? two high flying growth stocks struck down in their prime. are they broken companies or are their stocks just bent out of shape? cramer is seeing if it could be time to position yourself to profit. >> announcer: don't miss a second of "mad money." follow @jimcramer on twitter. have a question? tweet cramer, #madtweets. send jim an e-mail to madmoney@cnbc.com or give us a call at 1-800-743-cnbc. miss something? head to madmoney.cnbc.com.

oh, man. after a tough quarter, so many stocks got roughed up this quarter. one day left. time to talk about the best way to pick among the rubble. to search for the stocks that were obliterated in order to find the hidden gems. specifically tonight i'm going to teach you how to tell the difference between a broken stock on the one hand and a broken company on the other by looking at two momentum names that have suddenly been crushed. one we'll do after the break. i'm calling that a tease because that's tv lingo. first up, celgene, which i have gotten more tweets about than any other i follow. it's a big biotech firm with a host of major cancer drugs. long-time cramer fave growth

stock. a week ago it was annihilated, taken to the wood shed, hurting bad. what happened? last thursday we found out there might be a problem with the biggest drug, a $3.2 billion blockbuster treatment for blood cancers like multiple myeloma which is particularly nasty. we heard they would get approval for a first line treatment for multiple myeloma that the docs would use. celgene said they were pulling the european application. this was a shocker. it would have been for the expanded use of revlimid and the stock went through the meat grinder. they were counting on the european approval. it was in the numbers. so they had to race to cut those numbers. 19 firms that follow celgene cut their estimates for 2013. 15 firms cut numbers for 2014 by an average of 42 cents a share off a 693 cent basis. that's a hideous hair cut. no wonder celgene got slammed, falling from $67 and change to $59.44. 11.4% decline that shaved nearly $3.4 billion off the market cap. celgene is a growth stock. any time the company encounters

a hurdle that's a big deal. this european fiasco was especially problematic because management seemed so self-assured about the approval treating it as a when more than an if. it hurt the credibility with many investors and, boy, they had a lot of credibility built up over many years. to make matters worse on the same day onyx pharmaceuticals stock is good. they got the thumbs-up from the fda panel for the new multiple myeloma drug. the same disease treated by revlimid. it called the viability of

revlimid into question to have the competitor. we have had a week to process it and we have to ask is celgene a broken company meaning the business is worse than we thought and could a long time to recover, if at all. or is it merely a broken stock connected to an intact company? i have to tell you, this is the classic example of a broken stock. i believe the underlying business, while not as good as it was a week ago, is not that bad. it may actually be just fine over the next 18 months. the selling, therefore, is overdone. the stock is way too hated and that creates an opportunity for you to buy this excellent company people have put in here. you're buying it cheaply but only buy half now.

every dimwit and his brother are selling it to show their clients they weren't fooled when people see the holdings at the end of the quarter. then after, buy the rest. so put on half tomorrow. buy the rest after they report the next quarter at the end of july. i think they will tell a better story than last thursday. my confidence is misplaced. why am i confident that this is not a broken company? first of all, last week's bad news wasn't as surprising as you might think. at least to the shareholders. the stock had been telegraphing something was wrong for a good while before they learned they were pulling the european application. somebody knows something. i don't know. the stock just traded horrible. do you know since april celgene fell from $80 to $67 the day before the news hit. 16% decline in less than three months at a time when the drug and biotech groups were quite strong relative to the market. celgene was already selling at 11.8 times next year's earnings despite the fact they have a fabulous 23% long-term growth rate. incredibly cheap for a growth

stock. now they are cheaper, 11 times next year's reduced estimates. 11.3 to be exact. doesn't matter how cheap the stock is if the business is in decline. i think the business is doing just fine. this problem may not be as serious as the market is treating it. even if they announced they are pulling the expanded european application for the drug the company reaffirmed short and long-term guidance. why bother to do that if you don't have conviction? meanwhile, management believes the company can earn anywhere from 470 to 480 for 2012. they are forecasting $8 to $9 earnings power in 2015. that's huge, huge, huge. if celgene can make those numbers, not beat them, just simply meet forecasts this stock has become insanely cheap. sure the credibility has taken a hit and they are in show-me mode, but it's worth giving

management the benefit of the doubt. that has to do with my third reason for believing this is a broken stock. they have an excellent management team led by ceo bob eugin. in particular he has a history of being conservative with numbers. whatever problem celgene has, i believe he deserves the benefit of the doubt. i think he can fix them. fourth, the european issue is not the end of the world. celgene will resubmit the application with more mature data in the future. what really happened is the approval process got pushed back 12 to 18 months. that's not a franchise killer. it's a speed bump that will go away over time. revlimid is a huge drug here in the u.s. and the expansion in europe has been postponed. fifth, revlimid is a major part of the equation. there are other drugs including one for breast cancer, leukemia and t-cell lymphoma. the company has a fabulous

pipeline. no one is thinking about that. it should fuel growth for years to come. celgene has a next generation multiple myeloma treatment which could do more than a billion dollars in big sales. this drug is likely to come up for fda approval next february. one of the stories that crushed celgene's stock last week, onxx getting a positive report for the multiple myeloma drug last week was actually good news for celgene. in a way at least. it means the fda is likely to approve polylidimide. the company is conducting nine phase two and three studies to expand the use of drugs. they increased more than a billion dollars in additional sales. cegene is getting no credit for the new drugs and new indications nor the reaffirmation of earnings power. remember, next week we get the june employment number. i expect it to be weak. that will bring more money for the celgenes of the world, not away from them.

this is not a broken company. it's a broken stock with terrific management that's become way too cheap given its prospects. buy half now. as all the money managers knock it down even further tomorrow and buy the rest after celgene reports. after the break, i have another name for you. believe me, it's one you know. we'll answer the classic wall street conundrum as you pick among the rubble, broken company or broken stock? i'm judge, jury and executioner. stay with cramer. >> announcer: coming up, 20% off? this popular retailer stock took a bath when they reported, but cramer is browsing the aisles to find out if it's time to take advantage of the savings and go shopping or if the merchandise is damaged. and later, send cramer an e-mail to madmoney@cnbc.com. or tweet him @jimcramer #madtweets.

he might answer you on the air on an all new edition of mad mail, all coming up on "mad money." training's gotta be a lifelong passion... [ debbie ] michael! [ male announcer ] ...fueled by a footlong passion. that's why debbie phelps is always there for her son michael with his favorite flavor-packed, fully-jacked footlong subs. only one? michael... [ male announcer ] dive into michael's fav, the protein-powerhouse subway turkey & bacon avocado. made fresh for this champion with extra jalapeños. subway. the official training restaurant of the phelps family... and athletes everywhere. mike's being healthy and chewing like a man. introducing one-a-day vitacraves for men! it's a gummy multivitamin... with more vitamin b, to convert food to energy, and help mike do manly things, like wrestle bears and take out the garbage. new one-a-day vitacraves for men.

activating protection, bear! the more you move, the more it works! [ roars ] [ screaming ] new long lasting degree with motionsense help me! keep running! hands that feel soft and silky smooth! ooh...she's got the look. what's her secret? the gloves? dawn? i don't believe it. [ male announcer ] it's a dishwashing sensation... dawn hand renewal with olay beauty. it contains revitalizing proteins to help smooth skin on hands -- improving their look and feel in just five uses. [ sponge ] soft, smooth... fabulous! you're quite the trendsetter. [ male announcer ] dawn does more... [ sponge ] so it's not a chore.

in this tumultuous environment it's more important than ever to know the difference between a broken stock and a broken company. right now we have a lot of

stocks down big. some of them terrific. others, horrific death traps. tonight my mission is to make sure you can tell one from the other. we already talked about celgene which was eviscerated last week even as the underlying company is sound. we have another name put through the meat grinder. bed bath & beyond. going into last week it was a best of breed growth stock with fabulous momentum that was up an astounding 27% year to date. whenever a momentum name stumbles like we saw in nike tonight, the stock gets crushed like a tin can. that's exactly what happened to bed bath when it reported last wednesday after the close. the actual quarter was okay. the company delivered a 5 cent earnings beat and the revenues came in a little light. same store sales up 3%. significant deceleration from the prior quarter in the previous year. what really soured people on this one was the guidance.

for the next quarter bed bath & beyond forecast earnings between 97 cents to #1.03, less than the $1.08 a share that analysts were looking for and hoping for more than that. in part because it is forced to use more coupons to get people in stores and because of integration expenses from a spate of recent acquisitions. remember, investors care about the future, not the past. when a company reports guidance is everything. you can deliver the best quarterly results and the stock would still get hammered if you give a downbeat forecast. it's no wonder that bed bath & beyond stock was obliterated last thursday. the stock fell $12.50. 16.9% in a single day. market cap shrinking by $2.85 billion. since then, frankly, it's only been downhill. as managers rush to sell bed bath into the end of the quarter and the stock is down 20% from where it went out a week ago. holy cow. virtually all the gains for the

year have been erased like they don't have any idea what they are doing. is bed bath & beyond a broken stock or a broken company? the long-term growth story is intact and the market overreacted to the news. they are acting like it's falling off a cliff but that's not the case. management was simply being conservative. they were being cautious. that's something we have seen many times before from this company. i followed it from when it became public. bed bath & beyond has been down a number of times for the exact same reason. management gave conservative guidance and the stock got slammed. every one of those times the stock eventually bounced back. >> all aboard! >> as the company has a terrific long-term track record. the most likely explanation is that bed bath & beyond is doing what it's done better than any other retailer.

it is practicing upod. it's underpromising. i think they can overdeliver. the management talked about slowing trends. not saying that nothing is wrong here. but down 20%, come on. they indicated that sales decelerated, margins deteriorated. i believe these are problems that the company can and will fix. bed bath & beyond isn't best buy for instance where the business has no reason for being. other -- staff, put the boxes together when you -- no reason for being other than as a showroom for -- amazon.com. think about it. bed bath & beyond sells housewares. we know the housing market is recovering faster than expected and people are investing in their homes again. that's big. plus the consumer should have a lot more money in her pocket now that the price of gasoline has dropped so precipitously. these are both major positives

for bed bath which has 993 core bed bath & beyond stores in 50 states and the district of columbia, puerto rico and canada. the company believes it can grow to 1300 locations. they have a 31% store count increase coming and they have three other brands in position to grow. cramer daughter fave harmon, a health and beauty retailer. sometimes i feel like i have been to every one of them with my daughter. byebye baby. that should benefit as the number of births rebounds. we have had an incredible no growth period for babies here. that's going to rebound with the economy. also with the new growth of housing. then there is the christmas tree shops. not a fan. i don't find them great. but they sell food and toys to seasonal decorations like christmas trees. 71 stores in 20 states. up big from 23 stores when they acquired it and they like the business. they say good things on the

calls. the store expansion story is still very much intact. as for the weakness of the quarter and cautious guidance any improvement in the gross margins from selling a better mix of products could send the stock back up. so could continued improvement in an attempt to reign in sales and expenses which were down nicely in the latest quarter. as for the integration costs, bed bath & beyond recently bought linen holdings. they are now in the process of acquiring cost plus. a furniture and home decor retailer with over 270 stores for $490 million bucks. this caused the earnings guidance to disappoint. they have a proven track record of growing its acquisitions profitably. there are a lot of cuts that they can still make at cost plus to bring up the margins. i'm not worried about this. more importantly, this is a

fantastic well run chain by solid operators who will work hard not to let you down in the future. bed bath sells things you can't buy online. people say it will get hurt by amazon. i like everything -- i like to touch the stuff there. so does everybody else. you need to see this stuff in person. you always end up spending more than you plan. i always spend way too much in the candy aisle there. plus the company has a $600 million buyback authorization for the next three quarters and i have to assume they are buying down here. they're buying here given that the company has bought back $300 million in stock last quarter. $7 higher than where it is now. the stock is going from expensive to cheap in what may be a new land speed record trading at 11.7 times next year's earnings. it's like these guys walked on water two weeks ago and now they can't do anything right. they can't even make the boxes.

to me, they are solid operators who deserves benefit of the doubt, just like celgene. wait for them to report in september before putting on the rest of the position. i want to get to the whites of their eyes but i'm afraid of missing the move. that's what a high quality operator you've got. here's the bottom line. bed bath & beyond is a broken stock but not a broken company. the market severely overreacted to typically conservative guidance and the stock will rebound nicely as people realize this is a classic case of upod. underpromising and overdelivering. that's right. the bed bath & beyond bar is low enought that management will have no trouble trumping it. we have to take some calls. why don't we go to brad in california? bradley. >> caller: boo-yah, mr. cramer. dodger blue, will we ever score again greetings to you from sunny southern california.

>> you can always be in suffering philadelphia. what's going on? >> caller: i just had a question for you. we spoke a number of weeks ago. macy's has dropped from $42 to the upper $30s. caught in the european downdraft, whatever. >> right. >> caller: you felt at $35 it would be a strong buy and it has been. it's bounced back to $33 today. what are your feelings at this point? >> debra wineswig is worried about macy's. she talked about the empty pockets theory meaning the high end is not doing well. nordstrom, tiffany's, coach. i don't want to put macy's in the high end. i think they're doing fine. is it doing as well when it was at 42? no. it's at $33. it doesn't have to do as well as when it was at $42. we're okay with macy's. phil in washington, please. phil.

>> caller: a big boo-yah to you. >> i like it. what's going on? >> caller: you know, jim, i have been hanging on to chk, chesapeake energy for quite a while now. >> okay. >> caller: watched it going downhill. i believe in nat gas and i know it's going to happen for this country. but, gee, is chesapeake the play? >> look, chesapeake is a balance sheet story. they don't have a good balance sheet. it is very stretched. natural gas has to go up much higher for chesapeake to do well than every other nat gas stock i deal with. i'm not telling you to buy chesapeake because of balance sheet issues, not natural gas issues. as we reload for next quarter, it's time to look at knock down names and ask, do we have a broken stock or a broken company on our hands? when it comes to bed bath and beyond, i say broken stock, nothing more, because management is mastering the art of underpromising and

overdelivering. i think it will come back roaring. i want to stay with bed bath & beyond and i want to stay with cramer. >> announcer: coming up, the clock is ticking. call cramer at 1-800-743-cnbc to find out how to fire away at cramer on the lightning round. can he withstand your thunderous onslaught of stocks? and later, send cramer an e-mail to madmoney@cnbc.com or tweet him @jimcramer #madtweets and he might answer you on the air on an all new edition of mad mail. all coming up on "mad money."

>> it is time. it is time for the lightning round on cramer's "mad money." you say the name of the stock. i don't know the calls or the name of the stock ahead of time. i tell you whether to buy or sell. when you hear this sound -- [ buzzer ] -- then the lightning round is over. are you ready, skee-daddy? it's time for the lightning round on cramer's "mad money." want to start with nis in new jersey with nis. >> caller: b-b-boo-yah. >> boo-yah back. >> caller: i want to give a shoutout to my grandmother. >> thank you. >> caller: i was in ariad pharmaceuticals. >> as we saw the other day they

are paying off. i do like it. remember my thing. i said sell half and let the rest run. joe in illinois. >> caller: b-b-boo-yah, jim. >> what's up? >> caller: this is joe from the windy city of chicago. >> nice. >> caller: long-time listener, first time caller. i wonder what your opinion is on weight watchers. >> i still don't like it. remember, i said that was a dangerous stock. it continues to be dangerous. they bought back a lot of stock and it was foolhardy. i don't like weight watchers. mike in georgia. >> caller: this is mike in georgia. a big southeast boo-yah to you. >> what's up? >> caller: we've got ticker viv. brazilian telecom. you have the world cup and the olympics coming up. financial statement looks great. multiple bottom off a down

trend. what do you think? >> it makes sense to me, but i have vz with a similar yield and a better comfort level. i like your idea. i want to stick close to home right now. let's go to mary in texas. >> caller: hey, cramer. i am wishing you a very sweaty boo-yuck from garland. it's a dallas suburb. >> you know, deodorant boo-yah. what's up? >> caller: my stock is a fertilizer play. you talked about it before, mos, mosaic. it seems to have a lot fewer enterprise segments than dupont. what do you think? >> here's the problem. i think this ag trade has lasted four days. [ buzzer ] >> that's as long as they last. if we get rain this weekend -- >> sell, sell, sell. >> it's been a good trade but that's it. john in arizona, please. john. >> caller: what's up? i'm calling about sid.

i love brazil. it's a fat yield. >> no, no. brazil steel, economic slowdown. they have not been able to ignite the economy. the olympics should matter, i know, but i'm not going there. pat in south carolina. pat. >> caller: yes, jim. this is pat in south carolina. my husband wants to buy conoco-phillips. >> i bless it. almost a 5% yield. more than 3.5%, 4% is a good buy. big natural gas business and it's bottomed. i'm okay with buying cop. and that, ladies and gentlemen, is the conclusion of the lightning round. [ buzzer ] >> announcer: the lightning round is sponsored by td ameritrade. last? forty-five minutes? an hour? well... listen. 5-hour energy lasts a whole lot of hours. take one in the afternoon, and you'll feel alert and energized 'til the cows come home.

it's packed with b-vitamins and nutrients to make it last. so what's it going to be, partner? 5-hour energy. wise choice. 5-hour energy. hours and hours of energy. ♪ [ ping! ] [ ping! ping! ] that's why i use new tampax radiant. it helps keep my period invisible, combing tampax's best-ever leak protection with a revolutionary resealable wrapper so all they'll see is me. [ ping! ] ♪ hi. totally new, awesomely-invisible tampax radiant. check out the whole radiant collection.

i have to catch up on homework now. it builds up. first on monday kenny in new jersey asked about ironwood pharma. irwd. it stumped me but big. i said i would get back to him. this is a speculative emerging specialty pharma company in cambridge, mass that has yet to turn a profit. it is an event driven biotech name. it's main drug is for chronic constipation, what a relief, awaiting approval in the u.s. and europe. with a decision in september and the end of the year respectively. given the large number of constipation sufferers and the lack of competition it could be a major drug. it could reach peak sales of $2.7 billion in 2025. any approval would give ironwood a pop. that said, you know how i feel about these things.

this one you're playing fda roulette. the stock has already had a big run up. nearly 18% in the last month. it will sell off. if either the american or european decision dates are pushed back. of course it will be completely obliterated if the fda says no to the whole shooting match. i think ironwood could be intriguing spec for those of you with serious intestinal fortitude. next up, last thursday, dan in the illini asked about liquidity services. the company provides the most transparent online marketplaces and integrated services for surplus asset sales. we have a lot of that. with over 4500 selling clients, 1.7 million registered buyers worldwide. i see a number of dark clouds here. i'm not a fan. first, the chief financial officer recently said in a conference that margin expansion may slow going forward.

second the ceo filed to sell about 2.5 million shares, 40% of his stake. that level of insider selling, i find it discouraging. [ buzzer ] it's more than doubled over the last 12 months. it trades at a discount but the noted stock sage tina turner says we don't need another hero. don't be one. ring the register and step aside. you know what? now we do some tweets. you know how to find those. let's take our first tweet from that usaf_test. can you explain how master card stock has been able to rise over visa? they are doing better than master card. we do apples to apples when stocks by looking at the price to earnings multiple.

no. mastercard has not done better than visa now. here's one from buyaapl77. he tweets my pbr position is down to a five-year low. look at the 90 chart. i think he means 90-day. add here or take the pain? i think you let loose the pain and i think you -- sell, sell, sell. this one is not going to get there for you. remember, from now on pbr is not a stock. it's a darn good brewski. another one from @medscottd. he tweets visiting from california. took my kids to the nyse. they asked is this where jim cramer works. i laughed and said, among many others. i go out to englewood cliffs at night and i spend time with the cnbc people. i love post nine. if you come to new york, go to the stock exchange. it's one of the most exciting things you will ever do. take your kids. let's take another from

z28barnett. they say apple likely to buy micron tech. i'm floating the red flag. there is absolutely no way this will happen. if you own micron whether for rumor or not, sell, sell, sell. you don't want to be there. that is a nasty stock. stay with cramer. ♪

[ male announcer ] nothing will keep you from magnum. silky vanilla bean ice cream and rich caramel sauce all covered in thick belgian chocolate. magnum ice cream. for pleasure seekers. get two miracles in one product. tone rehab 2-in-1 foundation. covers spots, lines, and wrinkles. and helps improve skin tone over time. tone rehab from easy, breezy, beautiful, covergirl! covergirl! throughout our entire lives. ♪ one a day men's 50+ is a complete multi-vitamin designed for men's health concerns as we age. ♪ it has more of seven antioxidants to support cell health. that's one a day men's 50+ healthy advantage. properly inflated tires can

increase fuel efficiency by three percent. that's about 8 cents a gallon, and that can really add up over the next few years. see, going green can save you green the more you know.

lawlessness, utter lawlessness. that's all i can think after barclay's admitted traders tried to manipulate interest rates to make themselves look better and their employer seem more solvent. the london interbank offered rate is immensely important controlling everything from what corporations borrow at to what you may have had your mortgage priced off. it was sacrosanct. then come the trading pirates moving it wherever they wanted to perhaps in conspiracy with other traders to inflate bank share prices and get bonuses. you may ask why shouldn't they do this? the traders get caught. who pays the price? the shareholders. that's who. barclays agreed to pay $453 million in fines, the lead story in the wall street journal. it wasn't the people running barclay's.

it was the hapless owners who bore the cost. hey, geez, that's a horrendous percentage sell-off. the unusually steep punishments reflected the serious and widespread nature of the manipulation. huh? what the heck is steep about this punishment? isn't punishment supposed to be meted out to the wrongdoers? why are the shareholders penalized? what did they do? there were people involved in the price fixing. the fact they aren't paying the fine promotes lawlessness. we put mafia people in jail for years for fixing prices. we've indicted people for running numbers books, casinos. we put people in jail for fixing the price of electrical equipment, for cardboard boxes. i'm not kidding. these traders get to laugh all the way to the bank. i'm not even hearing about clawbacks of bonuses. they may have been enlarged by manipulating the most important contract.. how about the voice at the top? the chief executive and three

other top executives agreed to give up bonuses like they deserve it after that stock performance. i feel their pain. that's go forward money. how much did they make during and after the scams? bad enough the stock prices have been horrendous. they got rich at the same time, perhaps off of some of these actions. nobody ever seems to have to give up anything in banking. nobody loses their jobs or gets prosecuted. the job gives them immunity from all but insider trading. this immunity is one more injustice not unlike the immunity the bankers at countrywide, lehman, bear or aig received. these bankers were the cause of so many economic ills but somehow evaded the law. sadly you can only conclude banking is a lawless profession. to me these people are embezzlers. fraudsters.

perhaps gangsters in pinstripes. the immunity makes a mockery of justice and explains why so many calculate it's worth it to break the rules because even if they catch you all that happens is the shareholders pay. what a sweet deal these bankers have on the rest of us. shame on the governments for not pursuing them with everything they use to corral the petty price fixers and put them out of action for good. stay with cramer. >> all right. a lot of disappointments after the bell. nike, yes, i thought it could hold. that was a bad call. g to need t? three...four cups? [dumbfounded] well, we... doesn't last long does it? listen. 5-hour energy lasts a whole lot of hours. so you can get a lot done without refills. it's packed with b-vitamins and nutrients to make it last. so don't just stand there holding your lattes, boys. make your move. we'll take the 5-hour energy. smart move. 5-hour energy. hours and hours of energy. [ sound fades ]

at a moment like this, i don't care if my tampons come in a little black box. tampax pearl protects better than u by kotex. [ cheers and applause ] [ angie ] outsmart mother nature only with tampax. starts with arthritis pain and a choice. take tylenol or take aleve, the #1 recommended pain reliever by orthopedic doctors. just two aleve can keep pain away all day. back to the news.

>> all right. a lot of disappointments after the bell. nike, yes, i thought it could hold. that was a bad call. you have to own it. why do i like it? i said you could buy it for the olympics. i'm sticking by that. i think the company deserves more credit. research in motion, no credit. no nothing. research in motion, sorry. it just is still wrong. it's still too early to buy rimm. don't be fooled. the europeans aren't coming up with a compromise overnight. i will say this.